The Winship prostate cancer and genitourinary cancer teams include urologists, medical oncologists, radiation oncologists, advanced practice nurses and social workers. They work together to provide the most appropriate individualized approach to treating prostate cancer patients. The prostate cancer program is located at Winship Cancer Institute (Clifton campus), Winship at Emory Saint Joseph's and Winship at Emory Johns Creek Hospital.
Watch the video to meet some of the members of our multidisciplinary team of prostate cancer specialists.
Our collaborative approach to care offers a number of benefits to our patients, including:
- Access to nationally and internationally renowned as well as community-based experts in prostate cancer.
- Weekly review of patient cases by the full team of experts.
- Coordinated scheduling for appointments among various specialties.
- Access to a nurse navigator to assist you throughout the treatment process.
- Access to support programs and groups for you and your caregivers.
- Availability of new treatment options within our clinical trials program.
Most men will not experience any symptoms of prostate cancer if it is caught early. However, some men do, and these symptoms may include the following:
- A need to urinate frequently, especially at night
- Difficulty starting urination or holding back urine
- Weak or interrupted flow of urine
- Painful or burning urination
- Difficulty in having an erection
- Painful ejaculation
- Blood in urine or semen
- Frequent pain or stiffness in the lower back, hips, or upper thighs
Men who experience any of these symptoms should speak to their doctor.
These are some of the tests that may be used to confirm a diagnosis:
Prostate Specific Antigen (PSA) Tests: a blood test is used to assess the level of PSA in the blood. A higher-than-normal level of PSA might indicate a problem with the prostate, including cancer.
Digital Rectal Exam (DRE): a physician inserts a lubricated, gloved finger into the rectum to feel for abnormalities of the prostate.
An abnormal age-adjusted prostate specific antigen (PSA) test or abnormal digital rectal (DRE) exam is an indication of prostate cancer, but does not mean cancer is present. Abnormal findings should be followed by a biopsy of the prostate cells to determine whether they are in fact cancerous.
Biopsy: a biopsy is a procedure in which a sample of tissue is taken from the prostate and then viewed under a microscope to check for abnormalities.
Prostate Health Index (phi): still being studied, phi is a new, more precise blood test that better distinguishes an aggressive cancer from a low-risk cancer.
For recurring prostate cancer patients, we are currently offering a new clinical trial that allows physicians to better locate the site of recurrence which in turn can provide you with a more tailored treatment option. The technique, called FACBC, uses positron-emission tomography (PET). To learn more, please ask your physician or read our brochure.
Older patients with health problems and those with slow-growing cancers often treat prostate cancer as a chronic or long-term disease and take a disease management approach with just watchful waiting. Sometimes combinations of therapies like radiation therapy following surgery, or external radiation following brachytherapy implants is the best way to go.
Watch the video to learn about how we determine a treatment plan for patients with prostate cancer.
- Radical Perineal Prostatectomy
- Robotic Prostatectomy
- Open Retropubic Prostatectomy
Radiation therapy options:
- Brachytherapy (internal radiation therapy)
- External beam radiation therapy
- Three-dimensional conformal radiation therapy
- Intensity modulated radiation therapy
- Proton beam radiation therapy (available soon at the Emory Proton Therapy Center scheduled to open in late 2018.)
Learn more about radiation therapy treatments and services.
Hormone therapy (also called androgen deprivation therapy) may be used if surgery or radiation is not an option. Chemotherapy is sometimes considered if prostate cancer has spread outside the prostate gland and hormone therapy is no longer effective.
In addition to delivering the highest quality medical care, we recognize the importance of the psychological and emotional aspects of living with a cancer diagnosis and of dealing with treatment. Our supportive oncology team address these issues in a timely manner with additional support from counselors, nurse navigators, dietitians and social service professionals.
We understand that this is a very stressful time. We welcome your questions and requests for help.
Watch the video to learn what to expect on your first visit.
Your Treatment Team
- Physician Diagnosticians
- Nurse Navigators
- Adv Practice
- Support Services
- Clinical Trials
- As part of the genitourinary oncology team, Dr. Carthon treats patients with prostate, bladder, and renal cancers and other genitourinary malignancies.
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
- (404) 778-1900
- Board certified in clinical and anatomic pathology, Dr. Ellis specializes in urologic pathology (genitourinary) and non-neoplastic renal pathology.
- Assistant Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine
- (404) 712-5947
- Dr. Issa's clinical and research interests include urological oncology, stones, endourology, minimally invasive surgery, clinical outcomes, and healthcare economics and operational strategies.
- Professor, Department of Urology, Emory University School of Medicine
- (404) 778-4898
- Dr. Patel specializes in the treatment of genitourinary and gastrointestinal malignancies as well as the use of high-dose rate brachytherapy and stereotactic body radiation therapy.
- Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine
- (404) 778-3473